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ABSTRACT
Introduction. The prevalence of primary hyperpara-
thyroidism (PHPT) is expected to increase in devel-
oped nations as the aged population grows. This
review discusses issues related to PHPT in the elderly
population with a focus on differences in disease pre-
sentation, medical and surgical management, and
outcomes.
Methods. Literature review of English-language stud-
ies of PHPT or parathyroidectomy (PTx) in the elderly
was performed. Surgical literature reviewed included
original clinical studies published after 1990. Priority
was given to studies with >30 patients where institu-
tional practice and outcomes have not changed signifi-
cantly over time.
Results. Elderly patients primarily present with non-
classic symptoms of PHPT that can sometimes be
missed in favor of other diagnoses. They have equiva-
lent surgical outcomes, including morbidity, mortality,
and cure rates, compared with younger patients, al-
though their length of hospital stay is significantly
longer. Several recent studies demonstrate the safety
and efficacy of outpatient, minimally invasive parathy-
roidectomy in an elderly population. Patients are re-
ferred for PTx less frequently with each advancing
decade, although surgical referral patterns have in-
creased over time in centers that offer minimally inva-
sive parathyroidectomy. Elderly patients experience
increased fracture-free survival after PTx. The major-
ity of elderly patients report symptomatic relief postop-
eratively.
Conclusion. PTx can offer elderly patients with PHPT
improved quality of life. PTx is safe and effective in el-
derly patients, and advanced age alone should not deter
surgical referral. The Oncologist 2010;15:1273–1284
INTRODUCTION
Primary hyperparathyroidism (PHPT) predominantly af-
fects the elderly, with a peak incidence between ages 55 and
70. U.S. longitudinal population-based studies have found
that women 65–74 years old have an annual detection rate
of 99 cases per 100,000, compared with 15.7 per 100,000 in
the general population [1]. The U.S. population aged 65
years is projected to increase from 35 million in 2000 to 71
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million in 2030, at which time the elderly will account for
20% of the U.S. population [2]. The number of new PHPT
diagnoses in this country will likely increase in a parallel
fashion. The advent of multichannel biochemical analyzers
in the 1970s made chemistry panel testing commonplace.
The resultant phenomenon of calcium “screening” changed
the clinical presentation of PHPT such that most patients
presently identified with PHPT have asymptomatic or min-
imally symptomatic disease [1].
The natural history of PHPT suggests that symptoms of
hyperparathyroidism progress in nearly 40% of patients [3].
This becomes particularly important for management of the
disease in elderly patients as the life expectancy in older in-
dividuals increases. Whereas U.S. life expectancy at birth is
77.8 years, current average life expectancy at age 65 is 18.7
years (20.0 years for women), and at age 75 it is 12.0 years
[4]. In comparison, for Caucasians born in 1950, life ex-
pectancy for males was 66 years and for females it was 72
years [5]. Because of improved survivorship among the el-
derly, those living with PHPT today may be at higher risk
for the development of complications in comparison to
prior generations of elderly individuals.
It is well known that many diverse diseases present
atypically in the elderly [6]. For example, elderly patients
with acute myocardial infarction (MI) are more likely to
present with neurological symptoms and weakness, rather
than the classic symptom of crushing substernal chest pain
[7]. Similarly, elderly patients with PHPT are less likely to
present with kidney stones and more likely to present with
vague neuropsychiatric complaints than are younger pa-
tients [8, 9]. Although some literature suggests that most el-
derly patients present with asymptomatic disease, there is
concern that a substantial fraction of patients with PHPT are
being misclassified as “asymptomatic,” or just having
“symptoms of old age,” when they do, in fact, have specific
symptoms referable to PHPT.
Studies utilizing disease-specific questionnaires reveal
that 85%–90% of patients with PHPT have symptoms pre-
operatively that improve after surgery [10, 11]. These in-
clude a number of vague or subjective complaints such as
weakness, irritability, easy fatigability, bone or joint pain,
thirst, or itchy skin, which may be common in the general
elderly population. Unlike objective symptoms such as
nephrolithiasis or osteoporosis, nonclassic symptoms are
difficult to quantify. Recently, Pasieka et al. defined and
validated a survey tool that aims to better enumerate the im-
pact of nonclassic symptoms [12, 13].
Parathyroidectomy (PTx) offers the only definitive ther-
apy for PHPT, and multiple studies have demonstrated that
it can be performed in the elderly as an outpatient procedure
with low complication rates and outcomes that are equiva-
lent to those in younger patients [9, 14–16]. In a decision
model analysis, Zanocco and Sturgeon demonstrated that
surgical treatment of PHPT is cost effective for patients
over 50 years of age with a predicted life expectancy of 5
years or more [17]. Despite these facts, elderly patients are
much less likely to undergo PTx compared with their
younger counterparts, a phenomenon that is independently
attributable to age [8].
METHODS
A Medline search was conducted using the search terms
“primary hyperparathyroidism,” “parathyroidectomy,” and
“elderly.” English-language original clinical studies were
evaluated. Surgical reports published after 1990 were re-
viewed to accurately reflect modern standards in surgical
technique and perioperative care. Although other refer-
ences are made throughout this review, the studies repre-
sented in Table 1 are those that include both 30 patients
and do not span periods during which institutional tech-
niques and/or outcomes underwent substantial evolution.
CLINICAL PRESENTATION
Initial Evaluation of the Elderly Patient with
Primary Hyperparathyroidism
The biochemical diagnosis of PHPT is based on elevated
serum calcium in conjunction with inappropriately elevated
parathyroid hormone level. Calcium elevation on serum
panels typically triggers the workup in asymptomatic pa-
tients.
Thus, during the 1990 international consensus, the Na-
tional Institutes of Health defined biochemical criteria in-
tended to assist physicians in selecting “asymptomatic”
patients for surgical referral [18, 19]. A limitation of these
guidelines is the difficulty in defining asymptomatic dis-
ease.
Multiple studies demonstrate that elderly patients un-
dergoing PTx present with different symptoms than their
younger counterparts (Table 2). Bachar et al. found that pa-
tients 70 years were more likely to have hypertension
(18.9% versus 1%, p  0.0001), whereas those younger
than 70 years were more likely to experience kidney stones
(27% versus 14.3%, p  0.007) and peptic ulcer disease
(16.2% versus 7.4%, p  0.03) [20]. Politz and Norman
identified significantly more hypertension in patients 80
years, and significantly higher rates of sleep disturbances,
poor concentration, and irritability in younger patients [14].
Chen et al. found that patients70 years experienced more
mental impairment (42% versus 12%, p  0.001), fatigue
(39% versus 18%, p 0.025), and bone disease (33% ver-
sus 15%, p 0.005), whereas patients70 years presented
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with more nephrolithiasis (39% versus 19%, p 0.025) [9].
Uden et al. found that renal stones were 2.6 times more
common in younger patients60 years (p 0.001) and hy-
pertension 1.7 times more common in those60 years (p
0.05) [15].
Given the variety of PHPT presenting symptoms, sev-
eral studies of elderly patients with PHPT have used dis-
ease-specific symptom surveys to determine the impact of
PTx on health-related quality of life. Validated tools, such
as the Medical Outcomes Study Short-Form Health Survey
and the Health Outcomes Institute Health Status Question-
naire forms, have been used to help quantify the burden of
PHPT on health-related quality of life [21, 22]. Subse-
quently, the disease-specific PTx assessment of symptoms
score was developed and validated to better quantify the im-
pact of nonclassic symptoms, including joint or bone pain,
easy fatigability, abdominal pain, headaches, and feelings
of forgetfulness, depression, irritability, or weakness [12].
A 10-year follow-up report demonstrated that quality of life
was significantly better at 1 and 10 years post-PTx than pre-
operatively, compared with a group of post-thyroidectomy
controls [13].
In preoperative surveys, elderly patients undergoing
PTx most commonly complain of fatigue, bone pain or his-
tory of bone disease, and mental impairment, including
confusion, depression, or memory problems (Table 1).
Politz and Norman reported that the average elderly patient
referred for PTx most commonly had three PHPT-related
symptoms, with 97% reporting at least one symptom [14].
Whereas three studies found that asymptomatic patients
Table 1. Most common presenting symptoms and clinical disorders in elderly patients undergoing parathyroidectomy
Study Fatigue
Mental
impairmenta
Bone pain/
disease
Muscle
weakness HTN
Kidney
diseaseb Asymptomatic
Bachar et al. 20 11% 44% 11% 19% 14% 18%
Chen et al. 9 39% 42% 33% 19% 6%
Chigot et al. 25 35% 60% 15% 8%
Egan et al. 23 12% 6% 44% 20%
Irvin and Carneiro 24 15% 9% 50% 9% 15% 18%
Kebebew et al. 16 26% 50% 0%
Politz and Norman 14 62% 57% 44% 62% 15% 3%
Uden et al. 15 35% 31% 28% 47% 7%
aIncludes confusion and memory problems.
bIncludes nephrolithiasis.
Abbreviation: HTN, hypertension.
Table 2. Signs, symptoms, and clinical manifestations (conditions) of PHPT in the elderly
Musculoskeletal disease
signs and symptoms Neuropsychiatric disease signs and symptoms
Clinical manifestations
(conditions)
Osteoporosis Fatigue/lethargy/drowsiness Nephrolithiasis
Hip fractures Irritability Osteopenia
Bone pain Mood swings Weight loss
Joint pain Depression Hypertension
Vague muscle pains Cognitive disturbances/dementia/mental impairment/
memory loss/confusion
Hematuria
Constipation Bruising
Sleep pattern alterations Pancreatitis
Anxiety Gout
Apathy Peptic ulcer disease
Psychosis/paranoia/hallucinations
Coma
Neuroanesthesia
1275Morris, Zelada, Wu et al.
www.TheOncologist.com
comprised 18%–20% of their PHPT population [20, 23,
24], five others found asymptomatic patients to be8% of
the total [9, 14–16, 25]. One limitation of these data is se-
lection bias: all patients studied underwent PTx, likely lim-
iting the number of patients with truly asymptomatic
disease. In addition, the severity of symptoms is likely to be
higher in a patient population that ultimately was referred to
and elected to undergo surgical intervention. Finally, sur-
vey tools can sometimes bias results by prompting patients
toward a set of symptoms unrelated to their parathyroid dis-
ease.
Musculoskeletal Disease
As discussed, PHPT is a disease predominantly affecting
postmenopausal women, approximately 3% of whom will
develop the disease over their lifetimes [26]. Evidence sug-
gests that, in this population, decreased bone mineral den-
sity (BMD) translates into increased fracture risk. In a
retrospective, cohort study of 533 patients with PHPT fol-
lowed for an average of 7.4 years, osteoporosis was associ-
ated with an increased risk of fracture compared with
patients with normal BMD or osteopenia (hazard ratio [HR]
3.67; 95% confidence interval [CI]) 1.79, 7.51) [27]. Kebe-
bew and colleagues found that 26% of surgical patients
80 years of age with PHPT had osteoporosis and 20% had
a previous history of bone fractures [16]. Di Monaco et al.
found that a significantly higher percentage of elderly
women who had suffered hip fracture had biochemical ev-
idence of PHPT, compared with sex-matched controls
(4.7% versus 1.1%, p 0.01) [28]. In addition, in a Danish
observational study that followed 674 patients who under-
went PTx for PHPT, each compared with age- and gender-
matched controls, preoperative fracture risk was increased
in patients with PHPT (RR 1.8, 95% CI 1.3, 2.3), but nor-
malized postoperatively [29]. A long-term, prospective
study by Rubin et al. that followed 116 patients with PHPT
over 15 years found that, in patients who did not meet cri-
teria for surgery or refused surgical intervention, significant
reductions in femoral neck and distal radius BMD occurred
over time [3]. Given this observed decline in BMD in areas
commonly injured in falls, the implications of fracture risk
are of particular relevance to the elderly population.
Hip fractures are concerning in an elderly population
because of their associated morbidity and mortality. In the
Fracture Intervention Trial, which followed nearly 6,500 el-
derly women, the age-adjusted RR of dying over a 1-year
period following a hip fracture was markedly increased at
RR 6.68 (3.08, 14.52, 95% CI) and following a vertebral
fracture at RR 8.64 (4.45, 16.74, CI 95%). No increased
mortality was found following a non-hip or non-vertebral
fracture [30]. Braithwaite et al. used a Markov state transi-
tion model of the natural history of hip fracture to predict
that, after hip fracture in an 80 year old, remaining life ex-
pectancy declines by 25%, and survivors spend 17% of
their remaining life in a nursing facility. Lifetime cost of hip
fracture in this elderly population was estimated at $81,300
[31].
Neuropsychiatric Disease
There is now strong evidence to support the association of
PHPT with neurobehavioral symptoms, including fatigue,
irritability, mood swings, depression, and other mental dis-
orders, and alterations in sleep patterns [11, 32–35]. In a
case-control study of postmenopausal women, Walker et al.
found that patients with PHPT had significantly more
symptoms of subclinical depression and worse scores for
both immediate and delayed recall of contextually related
material compared with controls without PHPT. Symptoms
of depression were measured by the 21-item Beck Depres-
sion Inventory (a depression severity scale for adults). Al-
though these patients had depressive symptoms, they did
not meet the diagnostic criteria for major depressive disor-
der as defined by the Diagnostic and Statistical Manual of
Mental Disorders. Memory for contextually related mate-
rial was assessed using the Wechsler Memory Scale Logi-
cal Memory Test, Russell revision, which requires
examinees to repeat two brief, orally presented stories im-
mediately and after a 30-minute delay, evaluating units of
ideas recalled [36]. Both symptoms of depression and im-
mediate and delayed recall of contextually related material
improved significantly after PTx such that there was no dif-
ference in symptoms between the control group and the
postoperative group. Although lacking a control group, a
small, retrospective French study of patients 75 years
with PHPT found neuropsychiatric manifestations in 73%
of patients [37].
Cardiovascular Disease
Several European studies have reported an increased mor-
tality risk in patients with untreated PHPT related to cardio-
vascular conditions including MI, angina, hypertension,
congestive heart failure, and arrhythmias [38, 39]. Hedback
and Oden studied 4,461 patients operated on for PHPT in
Sweden over an 8-year period, control matched with the
whole population of Sweden for age, sex, and calendar
year. There was a significantly increased baseline risk of
death in PHPT patients compared with the general popula-
tion: 1.3 risk ratio in men (95% CI 1.07–1.57) and 1.61 in
women (95% CI 1.46 –1.78). Death from cardiovascular
disease was significantly increased in PHPT patients with
risk ratio for men of 1.71 (95% CI 1.34 –2.15) and for
women 1.85 (95% CI 1.62–2.11). The increase in cardio-
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vascular deaths was attributable to heart failure, MI, and
stroke [40]. Whether the risk of death from cardiovascular
disease declines after PTx still remains to be examined.
Although the European studies included patients of all
ages, risk of death from cardiovascular disease in patients
with PHPT is of particular importance in the elderly popu-
lation. Older patients present with more cardiovascular co-
morbidities than their younger counterparts. In fact, in
several studies of PTx in the elderly, 35%–72% of patients
who presented for PTx had hypertension, 15%–32% had
cardiac disease and 6%–11% had congestive heart failure
[20, 23–25, 41]. Although the question has not yet been spe-
cifically addressed, pre-existing cardiovascular disease
might make these patients more susceptible to the subse-
quent adverse cardiovascular effects of PHPT.
SURGICAL TREATMENT
Surgery remains the only definitive treatment for PHPT.
However, elderly patients are significantly less likely to un-
dergo PTx than young patients, even when they are gener-
ally healthy and eligible for surgery according to current
consensus criteria [8]. Published reports examining PTx in
the elderly are predominantly retrospective reviews of sin-
gle-institution surgical databases. Despite the inherent lim-
itations in these small studies, they demonstrate several
consistent themes.
ANESTHESIA
Most endocrine surgery centers in the studies reviewed
used general anesthesia with endotracheal intubation versus
laryngeal mask airway for PTx. Focused (minimally inva-
sive) PTx (MIP), made possible by accurate preoperative
localization studies (e.g., sestamibi or ultrasound), intraop-
erative parathyroid hormone monitoring (IOPTH), or intra-
operative radioguidance, can minimize operative time and
lower anesthesia requirements.
Use of both local and regional anesthesia for elderly pa-
tients can facilitate shorter stays in recovery, earlier dis-
charges, decreased need for postoperative narcotics, and
decreased postoperative cognitive dysfunction [35, 42–45].
Although general anesthesia does not increase the inci-
dence of postoperative delirium, some studies have demon-
strated a beneficial trend toward improved postoperative
cognitive function in elderly patients who received regional
versus general anesthesia. However, large trials in the an-
esthesia literature examined patients with 3-day postop-
erative hospital stays, which is less applicable to patients
undergoing mostly outpatient or short-stay procedures
[46, 47].
Our preferred method of anesthesia for MIP in elderly
patients involves a combination of sedation (propofol infu-
sion with intermittent doses of fentanyl) with a regional
block, unless contraindicated because of aspiration risk
(e.g., gastroesophageal reflux disease and morbid obesity).
A superficial cervical block is performed using 10 ml of
0.25% bupivacaine per side. The block is administered in
the subplatysmal plane along the posterior border of the
sternocleidomastoid muscle, unilaterally for patients with
well-localized adenomas and bilaterally for those with
poorly localized disease. At our institution, when given the
choice, two thirds of patients select this option over general
anesthesia.
Intrinsic to the overall care strategy for outpatient MIP
are methods proven to reduce postoperative delirium in the
elderly. A large study of general medicine patients from
Yale-New Haven Hospital examined 852 patients aged 70
years or older, without baseline dementia but at moderate to
high risk for development of dementia. Matched patients ei-
ther received “usual care” or were placed on a specialized
protocol with specific interventions designed to prevent de-
lirium (Table 4). The rate of delirium in the intervention
group was 9.9% versus 15% in the usual care group (p 
0.02). There was also a significant decrease in the number
of days and episodes of delirium in the intervention group
compared with the control, although median hospital length
of stay was not different between groups [48]. Outpatient
MIP targets a 3- to 4-hour postoperative observation period
and patients are assisted with ambulation in the recovery
area. Family members are encouraged to join the patients in
the postoperative care unit within 15 minutes of the conclu-
sion of surgery and can assist them with communication
(e.g., by bringing eyeglasses or hearing aids). Patients are
encouraged to drink liquids postoperatively, as soon as they
are fully awake. The need for narcotics is minimized by the
long-acting regional block (6–8 hour duration), which is
supplemented with a single dose of 30 mg of ketorolac as
needed in patients with normal renal function. Two thirds of
patients do not require any narcotic pain medications after
surgery, and no sedatives are given after emergence from
anesthesia.
Surgical Technique
Although traditionally PTx was accomplished via a four-
gland bilateral neck exploration (BNE), a more focused ap-
proach of excision of a single hyperfunctioning parathyroid
adenoma via a 2-cm incision is associated with shorter
operative time, decreased postoperative length of stay, de-
creased pain, more satisfactory cosmetic results, and bio-
chemical cure in 95% of patients [49].
Although BNE and minimally invasive parathyroidec-
tomy (MIP) have equivalent surgical success and compli-
cation rates in elderly patients [9, 16, 23–25], the
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introduction of MIP led to a change in surgical referral pat-
terns for the elderly. Both Pruhs et al. and Irvin and Car-
neiro found a significant increase in the proportion of
elderly (70–75 years) patients referred for PTx since the
introduction of MIP [50, 24].
In the minimally invasive era, BNE is now frequently
performed via a small incision under local anesthesia with
same-day discharge. In patients who do not have adequate
preoperative localizing studies or where IOPTH fails to de-
cline appropriately after excision of a localized parathyroid
adenoma, examination of the ipsilateral gland can be per-
formed via the same 2-cm MIP incision. Conversion to
four-gland exploration typically requires only a slight ex-
tension of a more centrally located incision to examine both
glands in the contralateral neck.
Pathology
MIP is based on excising a single, well-localized parathy-
roid adenoma and is applicable to up to 90% of patients with
sporadic PHPT [51] Most studies reported no difference in
parathyroid pathology between older and younger patients,
finding a single adenoma in 89%–97% of elderly patients
and hyperplasia in 0%–6% (Table 3) [9, 14, 52]. The two
studies that identified higher rates of double adenoma and
hyperplasia in elderly patients employed BNE for the ma-
jority of the cases [15, 16]. Elderly patients should be of-
fered MIP using the same algorithms as applied in younger
patients because the underlying pathology/rate of mul-
tigland disease is no different.
Length of Stay and Postoperative Delirium
Worldwide, there is wide variation in average length of
stay after PTx, between 2 hours for MIP and 4 days for
BNE. Generally, patients who undergo PTx by either
strategy are hospitalized for between 4 and 24 hours
postoperatively with patients undergoing BNE more fre-
quently admitted for an overnight observation. Multiple
studies have found that elderly patients have signifi-
cantly longer post-PTx hospitalizations compared with
younger patients, although lengths of stay were not
clearly defined by type of operation (BNE versus MIP)
[52, 53]. Although two studies reported that same-day
Table 3. Summary of results for studies on parathyroidectomy in the elderly
Study Study dates
Total
patients
Elderly
patients
Definition
of elderly Anesthesia
Type of
operation Pathology
%
Cure Complication
Mortality
(%) LOS (day)
Bachar 20 Jan 1996 to
Feb 2006
951 190 70 NS NS NS 94.8 11% 0 4  3.6
Biertho 44 Sep 1998 to
Jan 2002
220 40 70 82.5% IV sedation 
local,17.5% GET
UNE SA 92.5%, DA
2.5%,
carcinoma 5%
100 1 (2.5%) 0.1
Chen 9 Aug 1990 to
May 1996
184 36 70 GET BNE SA 89%, DA
11%,
hyperplasia 0%
94.4 5.5% 0 2.1  0.2
Chigot 25 Jan 1978 to
Dec 1992
542 78 75 GET BNE SA 95%, DA
4%,
hyperplasia 1%
100 7.7% 3 (4%) 4
Egan 23 Mar 2001 to
Jun 2006
50 80 NS NS SA 90%, DA
4%,
hyperplasia 6%
98 4% 0 0.5  0.1
Irvin 24 1993–2000 291 34 75 NS 85% UNE,
15% BNE
SA 97% 97 NS 1 (3%) NS
Kebebew 16 Jun 1996 to
Feb 2001
1,482 54 80 98% GET, 2% local 78% BNE,
13% UNE,
9.3% MIP
SA 74%, DA
15%,
hyperplasia
11%
NS 9.3%: 0 1.9  1.8
Politz 14 May 2003 to
Jul 2006
2,600 150 80 IV sedation and local
per protocol
MIRP SA 91%, DA
7%,
hyperplasia 2%
99.3 7.3% 0 0.08  0.008
Shin 43 Jan 2005 to
Dec 2007
388 101 70 NS 90% MIP,
10% BNE
31.4% multiple
gland resection
96.4 5.9% 0.63
Stechman 52 Jan 2002 to
Nov 2007
224 56 75 NS 66% MIP NS 96.8 0 1.6
Uden 15 1980–1990 250 131 60 GET BNE SA 77%, DA
9%,
hyperplasia
14%
98.8 4.6% 0 NS
Young 53 1998–2007 687 247 65 NS BNE versus
MIRP
NS NS 8.8% 3 (1%) 0.5  0.1
Abbreviations: BNE, bilateral neck (four-gland) exploration; DA, double adenoma; GET, general endotracheal intubation;
MGD, multigland disease; MIP, minimally invasive parathyroidectomy; MIRP, minimally invasive radioguided
parathyroidectomy; NS, not stated; SA, single adenoma; UNE, unilateral neck exploration.
1278 Parathyroidectomy in the Elderly
discharge is half as likely in elderly versus younger pa-
tients at the same institutions [52, 53], other studies
found no difference [9, 14, 43]. Recent shortened lengths
of stay in all patients have been attributed to the intro-
duction of minimally invasive techniques [50, 52].
There exists a considerable potential benefit to same-
day discharge for elderly patients in that they can quickly
return to their familiar home environment, minimizing the
risk of confusion and delirium from sleep deprivation, as
well as reducing the risk of falls, infections, and other hos-
pital-related complications common in elderly patients
[43]. In one report, 25% of elderly patients who stayed in
the hospital for more than 1 night post-PTx experienced
confusion [52]. Onset of postoperative delirium occurs, on
average, after 2 hospital days, and rates of delirium are sig-
nificantly increased in patients with older age, impaired
functional status, pre-existing dementia, and pre-existing
comorbidities [54]. Subjects who developed delirium had
significantly worse outcomes, including increased length of
stay and higher rates of discharge to long-term care facili-
ties [54, 55]. As evidenced in the Yale-New Haven Hospital
study on avoidance of delirium in elderly patients, proto-
cols that work to immediately return patients to their home
environment with resumption of normal activity are most
effective in reducing the incidence of postoperative delir-
ium (Table 4).
PREOPERATIVE COMORBIDITY
On average, older patients present with more comorbid
conditions than their younger counterparts. In surgical se-
ries, 78%–88% of elderly patients aged 70 years and older
referred for PTx have at least one comorbid condition, com-
pared with 55% of younger patients [20, 25]. A recent study
examining all patients with the biochemical diagnosis of
PHPT within a large health maintenance organization
showed that the proportion of patients with a Charlson Co-
morbidity Score of 1 or less was 95% in patients under age
50 years and 67% in patients aged 80 years or greater. In
other words, despite age-related declines in overall health,
the majority of older patients with PHPT are free from ma-
jor comorbities [8]. Shin et al. found that patients aged 70
years and older present with a greater severity of certain
complications of parathyroid disease, including a higher
median preoperative creatinine (2.0 versus 1.0, p  0.002)
and worse median BMD T score (2.5 versus 1.8, p 
0.001), relative to younger patients [43]. Despite these sur-
gical risks, elderly patients undergoing PTx have been re-
ported to have outcomes that are similar to those of younger
patients.
Major and Minor Complications
The perioperative morbidity (4%–10%) and mortality (0%–
4%) for elderly patients is similar to that of the general pop-
ulation. Table 3 lists the percentage of complications in the
elderly PHPT populations in each study reviewed, whereas
Figure 1 lists the number of patients experiencing each
complication across all studies that provided the number of
specific complications [9, 14–16, 20, 23, 25]. Transient hy-
pocalcemia is the most common complication of PTx, fol-
lowed by infection and hoarseness from temporary
recurrent laryngeal nerve injury. One report found that el-
derly patients are significantly more likely to experience
cardiac complications than younger patients (2.8% versus
0.5%, p  0.022), although this is rare even in elderly pa-
tients [53]. Mortality is uncommon after PTx, approaching
1% in some large studies of elderly patients undergoing
PTx, and typically can be attributed to significant to comor-
bid conditions [25, 44, 24, 53].
Figure 1. Number and type of postoperative complications
after parathyroidectomy in the elderly. This figure highlights
the 55 complications that occurred in 1,079 patients in 9 stud-
ies, with an overall complication rate of 5.1%. Abbreviations:
CHF, UTI, DVT, PE.
Table 4. Measures to prevent delirium in hospitalized
patients older than 70 years
Avoidance of sleep deprivation and use of nonpharmacologic
sleep protocol
Early mobilization protocol
Improvement in communication methods to avoid
exacerbating visual or hearing impairment
Prevention of dehydration
Adapted from Inouye S, Bogardus S, Charpentier P, Leo-
Summers L, Acampora D, Holford T, Cooney L. A
multicomponent intervention to prevent delirium in
hospitalized older patients. N Engl J Med 1999;340:
669–676.
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Biochemical Resolution
Cure rates reported after PTx in the elderly are the same as
those in younger populations, ranging from 94.4% to 100%.
None of the reviewed studies reported any significant dif-
ference in cure rates, as measured by biochemical indices,
between elderly and younger patient populations.
BENEFITS OF SURGICAL INTERVENTION
Although validated assessment tools are now available,
many studies have used internally constructed surveys to
assess symptom relief post-PTx. Various studies have re-
ported that between 64% and 90% of elderly patients expe-
rienced some or marked improvement in symptoms 1 year
post-PTx [9, 23, 25, 44, 52]. Approximately 2%–5% of pa-
tients felt that their symptoms were worse postoperatively,
whereas up to 32% of patients reported no improvement in
symptoms [9, 15, 24, 25]. Stechman et al. used the validated
PTx assessment of symptoms to measure change in symp-
toms post-PTx. Patients in all age groups experienced a sig-
nificant improvement in symptoms, with 87% of patients
75 years reporting an improvement in symptoms postop-
eratively [52].
Improved Bone Mineral Density
Following PTx, patients experience an increase in BMD
and a decreased risk of fracture. In fact, these outcomes may
in part explain why one longitudinal study found that the
primary reason for referral for PTx has shifted progres-
sively toward the presence of osteoporosis, climbing from
7% in 1985 to 20% in 2005 (p  0.03) [56]. Undoubtedly,
another key factor in this change in referral basis has been
the increasing use of BMD to accurately detect significant
bone loss in patients with PHPT.
Several large, retrospective cohort studies of patients
with PHPT have demonstrated improved fracture-free sur-
vival and decreased risk of fracture post-PTx, although one
Danish study failed to show such a benefit. In a large, ret-
rospective cohort study by VanderWalde et al. of over
1,500 patients with PHPT who either underwent PTx
(28.8%) or observation (71.2%), the 10-year fracture-free
survival after the diagnosis of PHPT was significant higher
in the operative group (73% versus 59%, p  0.001). Spe-
cifically, PTx patients experienced an 8% decrease (p 
0.001) in the 10-year fracture rate in the hip and a 3% de-
crease (p 0.02) in upper extremity fractures as compared
with patients with PHPT who did not undergo PTx [57]. A
follow-up study to determine the influence of BMD on frac-
ture risk post-PTx found that compared with observation,
PTx decreased the risk of fracture in patients with normal,
osteopenic, and osteoporotic BMD values, with the largest
impact being in patients with osteoporosis [58]. A large,
Danish observational study that followed 1,200 PHPT pa-
tients, each compared with three age- and gender-matched
controls, failed to demonstrate an effect of surgery on frac-
ture risk [39]. However, in a similar nationwide Danish co-
hort study, patients with PHPT who underwent surgery had
a lower fracture risk than those treated conservatively [58].
Three randomized, controlled trials have demonstrated
benefit with respect to increased BMD post-PTx. A small,
randomized controlled trial in mild, asymptomatic PHPT
found that, in patients randomized to surgery (n  25),
BMD increased significantly postoperatively in the spine,
femoral neck, total hip, and forearm. In contrast, in patients
randomized to follow-up (n 28), BMD increased slightly
in the lumbar spine (0.5% per year, p  0.09) and signifi-
cantly in the forearm (0.2% per year, p  0.05), while de-
clining in the femoral neck (0.4% per year, p  0.12)
[59]. A similar, small, randomized controlled trial of post-
menopausal Swedish women with asymptomatic PHPT
found decreased baseline BMD in the lumbar spine and
femoral neck in PHPT patients compared with age-matched
controls. A subset analysis of women 67 years old at the
time of study entry who underwent PTx demonstrated an
increase in total body BMD by 2.0% (p  0.01) over the
5-year period, without any such difference seen in age-
stratified controls. BMD in this group did not change in the
lumbar spine or femoral neck postoperatively [60].
A European study of 191 patients who either underwent
PTx or observation for mild asymptomatic PHPT demon-
strated a significant increase in lumbar spine BMD at 2
years post-PTx (p 0.05) compared with baseline and con-
trol values, with a trend toward a significant increase in
BMD in the femoral neck (p  0.07) [61].
Together, these data suggest that, in elderly patients, in-
cluding those with asymptomatic PHPT recognized only
via screening, PTx is beneficial in improving BMD and in-
creasing fracture-free survival.
Improved Neuropsychiatric Symptoms
Many studies have demonstrated improvement in subjec-
tive neuropsychiatric symptoms post-PTx, although most
have utilized institutional survey-based tools to assess pre-
and postoperative symptoms. Kebebew et al. showed a sig-
nificant improvement in fatigue, weight loss, depression,
nocturia, bone pain, and constipation, specifically in pa-
tients 80 years [16]. Several other studies have similarly
found improvements over a wide domain of neuropsychiat-
ric symptoms, although most outcomes were measured
without validated, formal neuropsychological tests [33,
62].
More recently, Perrier et al. performed a pilot random-
ized, controlled trial (n 18) to objectively measure differ-
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ences in neurobehavioral symptoms associated with mild,
asymptomatic PHPT in patients with a mean age of 63
years. Objective tests, including functional magnetic reso-
nance imaging, actigraphy for sleep assessment, and a val-
idated neuropsychological battery were used to document
the effect of improved sleep post-PTx. At 6 weeks postop-
eratively, hypersomnolence was increased in the observa-
tion group but decreased in the PTx group (p  0.03). The
trend continued at 6 months without statistical significance
[35].
Another randomized, controlled trial involving patients
with a mean age of 65 years examined quality of life in pa-
tients with mild, asymptomatic PHPT. Quality of life was
assessed with two validated, standardized questionnaires,
preoperatively and every 6 months for 2 years post-PTx. A
statistically beneficial effect of PTx was demonstrated in
areas of social and emotional role function. Patients who
did not have surgery experienced a significant decline in the
domains of social functioning, physical problems, emo-
tional problems, energy, and health perception (5 of 9 do-
mains). In contrast, patients undergoing PTx experienced a
significant decline only in physical function score, whereas
five other domains showed small, nonsignificant declines
[59].
The literature on neuropsychiatric function in PHPT
is interspersed with anecdotal reports of striking lifestyle
improvements post- PTx in elderly patients. In a study by
Chen, one patient reported being able to “throw away her
cane and walk unassisted” after PTx for PHPT [9]. A
number of case reports describe similar findings [63, 64].
Our institutional experience likewise confirms that el-
derly patients often make substantive gains in cognition
and sensorimotor function when rendered eucalcemic.
Some examples include an 83-year-old woman who re-
turned to playing chess with her son, an aphasic 90-year-
old woman who regained the ability to sing and
participate in family activities, and a 67-year-old woman
about to be institutionalized for Parkinsonism who re-
turned to the family home with adequate performance of
activities of daily living within a few weeks postopera-
tively. Objectively and subjectively, resolution of hyper-
calcemia can produce profound impacts on the quality of
life in the geriatric population.
IMPROVEMENT IN CARDIOVASCULAR DISEASE
Cardiovascular benefits have been reported after PTx but
have not been studied in the geriatric population specifi-
cally. Successful PTx has been reported to result in reversal
of left ventricular hypertrophy and a halt in progressive cal-
cification [33, 65]. Vestergaard et al. compared 674 Danish
patients with PHPT undergoing PTx with 2,021 age- and
gender-matched controls. They identified an increased risk
of acute MI starting a decade prior to surgery, declining to a
normal level 1 year following surgery (preoperative RR 1.9,
95% CI 1.2–3.0; 1 year postoperative RR 0.9, 95% CI 0.5–
1.5). Patients with cardiovascular disease experienced an
increased mortality, with hypertension being the main fac-
tor in the excess mortality (RR 2.29, 95% CI 1.09–4.82)
[39]. The findings have not been replicated outside of Scan-
dinavia. In fact, a 28-year population-based study in Min-
nesota found a relative risk of death of 0.69 in patients with
PHPT compared with controls (95% CI 0.57–0.83). How-
ever, elevated serum calcium level was an independent pre-
dictor for mortality in this study [66].
AGE-BASED BIAS AND DELAYS IN REFERRAL
Despite the considerable accumulated evidence indicating
that PTx is a safe and effective treatment for PHPT, elderly
patients frequently do not receive surgery. A recent, large,
population-based study reported that whereas 41% of pa-
tients with PHPT who were50 years of age received PTx,
only 17% of patients aged 70–79 years and 5.1% of patients
aged 80 years with PHPT were treated surgically [8].
Other studies support the conclusion that elderly patients
are undertreated [9, 16]. Additionally, Kebebew et al. found
that one fourth of patients 80 years with PHPT experi-
enced delays in surgical referral of 1 year. Among these
patients, two developed hypercalcemic crisis and acute de-
lirium [16]. Others developed progressive osteoporosis and
kidney stones in the interval between diagnosis and treat-
ment [8, 9, 16].
Despite the evidence supporting equivalent operative
outcomes in elderly patients, many primary providers still
do not accept PTx as a safe option for their patients. This
reluctance may be due to preconceptions about the out-
comes of parathyroid surgery. At high-volume endocrine
surgery centers, experienced parathyroid surgeons rou-
tinely perform PTx using the minimally invasive tech-
niques described. Referring elderly patients to a high-
volume parathyroid surgeon is crucial to achieving the
highest cure rates, lowest complication rates, and shortest
length of stay [67, 68]. With these achievable outcomes and
recent evidence that outpatient PTx is cost effective for the
management of PHPT in older patients with life expectancy
5 years, primary care providers should reconsider referral
of elderly patients for PTx [17].
LIMITATIONS OF STUDIES
Many of the current randomized, controlled trials evaluat-
ing PTx versus observation in elderly patients involve rel-
atively small patient numbers, and few have followed
patients long term. Also, surgical studies all consist of ret-
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rospective reviews of elderly patients undergoing PTx, de-
rived from surgical databases. They provide no information
on the natural history of PHPT in the elderly, and cannot be
used to compare surgical versus medical treatment. Large,
prospective trials of elderly patients with PHPT random-
ized to surgical versus medical treatment are needed to de-
finitively evaluate the safety and efficacy of surgical
management of PHPT in older patients.
CONCLUSION
The prevalence of PHPT will increase with the growth of
the elderly population. Elderly patients often present with
nonclassic symptoms of PHPT, including weakness, fa-
tigue, bone pain, confusion, and memory problems, which
impact their quality of life. They also have lower BMD val-
ues than their younger counterparts. Although many studies
to date are retrospective in nature and evaluate patients
from surgical databases, the studies reviewed here consis-
tently demonstrate that PTx yields similar outcomes, in
terms of morbidity, mortality, and cure, in both elderly and
younger patients. MIP can be performed under local anes-
thesia and as an outpatient procedure, thereby minimizing
the cardiopulmonary risk of general anesthesia and allow-
ing elderly patients a rapid return to their home environ-
ment. Both subjective and objective assessments of elderly
patients post-PTx clearly show improvements in quality of
life and increased fracture-free survival. In spite of these re-
sults, even symptomatic elderly patients are often not being
referred for PTx despite the potential serious consequences
of untreated PHPT. We anticipate that the application of
new validated tools for symptom assessment, combined
with an increased awareness of the favorable risk/benefit
profile offered by minimally invasive surgical techniques,
should lead to more appropriate treatment of PHPT in an
aging population.
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